Owren, P.A.: Coagulation of blood. North-west Med., 56: 31, 1957.
2.
Hougie, C., Barrow, E.M., AND Graham, J.B.: Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogenous group heretofore called "stable factor" (SPCA, proconvertin, factor VII) deficiency. J. Clin. Invest.,36: 485, 1957.
3.
Hjort, P.: Intermediate reactions in the coagulation of blood with tissue thromboplastin, convertin, accelerin, prothrombinase. Scandinav. J. Clin. &Lab. Invest., Suppl. 27, 9: 1957.
4.
De Nicola, P. : Factor VII (SPCA); its physiopathologic significance . Blood, 7: 947, 1953.
5.
Poller, L.: Thrombosis and factor VII activity. J. Clin. Path.,10: 348, 1957.
6.
Georgatsos, J.G., Hussey, C.V., AND Quick, A.J.: Nature and action of a new clotting factor obtained from erythrocytes. Am. J. Physiol., 181: 30, 1955.
7.
Rapaport, S.I. , AND Ames, S.B.: Anti-heparin activity of erythrocyte hemolysate. Proc. Soc. Exper. Biol. &Med., 95: 158, 1957.
8.
Frick, P.G.: Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer. Acta haemat.,16: 11, 1956.
9.
Graham, J.H. , Emerson, C.P., AND Anglem, T.J.: Postoperative hypofibrinogenemia; diffuse intravascular thrombosis after fibrinogen administration. New England J. Med., 257: 101, 1957.
10.
Rapaport, S.I. , AND Chapman, C.G.: Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. Am. J. Med., in press.27: 144, 1959.
11.
Langdell, R.D. , Wagner, R.H., AND Brinkhous , K.M.: Effect of antihemophilic factor on one-stage clotting tests. J. Lab. & Clin. Med. , 41: 637, 1953.
12.
Owren, P.A. , AND Aas, K.: The control of Dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scandinav. J. Clin. & Lab. Invest.,3: 201, 1951.
13.
Ratnoff, O.D. , AND Rosenblum, J.: Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition . Am. J. Med., 25: 160, 1958.
14.
Waaler, B.: Contact activation in the intrinsic blood clotting system. Scandinav. J. Clin. &Lab. Invest., Suppl. 37, 1959.
15.
Rouser, G., AND White, S.G.: Phospholipid structure and thromboplastic activity. Clin. Res., 6: 79, 1958.
16.
Troup, S.B., AND Reed, C.F.: Platelet thromboplastic factor; its chemical nature, in vitro activity, and the identification of similar thromboplastic substances in red blood cells . Program of the 50th Annual Meeting of the American Society for Clinical Investigation, May 1958.
17.
Bergsagel, D.E.: Viscous metamorphosis of platelets; morphological platelet changes induced by an intermediate product of blood thromboplastin formation. Brit. J. Haemat., 2: 130, 1956.
18.
Epstein, E. , AND Quick, A.J.: Effect of injecting platelet extract intravenously. Proc. Soc. Exper. Biol. &Med., 83: 453, 1953.
19.
Spaet, T.H. , AND Kropatkin, M.: Effect of intravenous soy bean phosphatides on blood coagulation in rabbits. Proc. Soc. Exper. Biol. &Med., 95: 492, 1957.
20.
Krevans, J.R. , Jackson, D.P., Conley, C.L., AND Hartmann , R.C.: The nature of the hemorrhagic disorder accompanying hemolytic transfusion reactions in man. Blood, 12: 834, 1957.
21.
Waaler, B.A. : Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. Scandinav. J. Clin. &Lab. Invest., 9: 322, 1957.
